カート
レポートナンバー 0000034046
VPGMarketResearch
2023 Russia Molecular Diagnostics Market: 2022 Supplier Shares, Instrumentation Installed Base and Strategies, 2022-2027 Volume and Sales Segment Forecasts for Individual Infectious, Genetic, Cancer, Forensic and Paternity Tests
発刊日 2023/01/23
言語英語
体裁PDF
ライセンス/価格
0000034046
※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。 ※本レポートは、英文です。電子媒体での納品となります。 ※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。
無料サンプル
このデータベースは、2022 年のサプライヤーのシェア、2022 年から 2027 年の感染症、遺伝子疾患、がん診断、法医学、および父子鑑定のアプリケーションに対する検査件数と売上予測、ならびに主要検査の新しい技術や製品を開発または販売している企業の包括的なリストを提供します。
調査範囲
List of Tables Molecular Diagnostics Test Volume and Sales Forecasts by Major Application Molecular Diagnostics Test Volume by Major Application Major Infectious Disease Test Volume by Assay Major Infectious Disease Test Volume by Method Molecular Diagnostics Market by Major Application Major Infectious Disease Diagnostics Market by Assay Major Companies Developing or Marketing Salmonella Molecular Diagnostic Tests Major Companies Developing or Marketing AIDS Molecular Diagnostic Tests Major Companies Developing or Marketing Adenovirus Molecular Diagnostic Tests Major Companies Developing or Marketing Bartonella Molecular Diagnostic Tests Major Companies Developing or Marketing Campylobacter Molecular Diagnostic Tests Major Companies Developing or Marketing Candida Molecular Diagnostic Tests Major Companies Developing or Marketing Chlamydia Molecular Diagnostic Tests Major Companies Developing or Marketing Clostridium Molecular Diagnostic Tests Major Companies Developing or Marketing Coronavirus Molecular Diagnostic Tests Major Companies Developing or Marketing Cryptosporidium Molecular Diagnostic Tests Major Companies Developing or Marketing CMV Molecular Diagnostic Tests Major Companies Developing or Marketing Echovirus Molecular Diagnostic tests Major Companies Developing or Marketing Enterovirus Molecular Diagnostic tests Major Companies Developing or Marketing EBV Molecular Diagnostic Tests Major Companies Developing or Marketing Giardia Molecular Diagnostic Tests Major Companies Developing or Marketing Gonorrhea Molecular Diagnostic Tests Major Companies Developing or Marketing Hantavirus Molecular Diagnostic Tests Major Companies Developing or Marketing Helicobacter Molecular Diagnostic Tests Major Companies Developing or Marketing Hepatitis Molecular Diagnostic Tests Major Companies Developing or Marketing Herpes Molecular Diagnostic Tests Major Companies Developing or Marketing Influenza Molecular Diagnostic Tests Major Companies Developing or Marketing Legionella Molecular Diagnostic Tests Major Companies Developing or Marketing Lyme Disease Molecular Diagnostic Tests Major Companies Developing or Marketing Measles Molecular Diagnostic Tests Major Companies Developing or Marketing Meningitis Molecular Diagnostic Tests Major Companies Developing or Marketing Mononucleosis Molecular Diagnostic Tests Major Companies Developing or Marketing Mumps Molecular Diagnostic Tests Major Companies Developing or Marketing Mycoplasma Molecular Diagnostic Tests Major Companies Developing or Marketing Pneumonia Molecular Diagnostic Tests Major Companies Developing or Marketing RSV Molecular Diagnostic Tests Major Companies Developing or Marketing Rotavirus Molecular Diagnostic Tests Major Companies Developing or Marketing Rubella Molecular Diagnostic Tests Major Companies Developing or Marketing Septicemia Molecular Diagnostic Tests Major Companies Developing or Marketing Shigella Molecular Diagnostic Tests Major Companies Developing or Marketing Streptococci Molecular Diagnostic Tests Major Companies Developing or Marketing Syphilis Molecular Diagnostic Tests Major Companies Developing or Marketing Toxoplasmosis Molecular Diagnostic Tests Major Companies Developing or Marketing Trichomonas Molecular Diagnostic Tests Major Companies Developing or Marketing Tuberculosis Molecular Diagnostic Tests Oncogenes Potential Application in Cancer Diagnosis Major Companies Developing or Marketing Cancer Molecular Diagnostic Tests Major Companies Developing or Marketing Molecular Diagnostic Tests For Genetic Diseases
この商品のレポートナンバー
2023 U.S. Molecular Diagnostics Market: 2022 Supplier Shares, Instrumentation Installed Base and Strategies, 2022-2027 Volume and Sales Segment Forecasts for Individual Infectious, Genetic, Cancer, Forensic and Paternity Tests
2023/01/23
1,850 USD